Charles Conover

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Research & Development, Program Management Enzon Pharmaceuticals Inc Jan. 1, 2012 - March 1, 2013
Vice President - Program Management and Compliance Enzon Pharmaceuticals Inc Jan. 1, 2011 - Jan. 1, 2012
Charles Conover's trades of Enzon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2012-06-06 2012-06-05
S Sale
83,586 +18.2%
252.58
US$1,309,445 		83,586 +18.2% 252.58 US$1,309,445